Cargando…
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
SIMPLE SUMMARY: Glioblastoma (GB) is the deadliest type of primary brain tumor. Following diagnosis the patient´s median survival is only 16 months. There are currently around 450 clinical trials focused on the development of more effective therapies for GB. Nevertheless, radiotherapy remains the mo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867045/ https://www.ncbi.nlm.nih.gov/pubmed/33535436 http://dx.doi.org/10.3390/cancers13030542 |